2019
DOI: 10.1134/s1068162019040101
|View full text |Cite
|
Sign up to set email alerts
|

Immune Checkpoints of the B7 Family. Part 1. General Characteristics and First Representatives: B7-1, B7-2, B7-H1, B7-H2, and B7-DC

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(17 citation statements)
references
References 138 publications
0
16
0
1
Order By: Relevance
“…Inhibitory immune checkpoints substantially regulate T cells' aberrant activation and terminate the AID 22 . The B7 family belongs to immune checkpoints, which their interactions with different receptors can elicit both stimulatory and inhibitory signals 23 . These family members are pivotal health and disease modulators of immune function 24 .…”
Section: Immune Checkpointsmentioning
confidence: 99%
“…Inhibitory immune checkpoints substantially regulate T cells' aberrant activation and terminate the AID 22 . The B7 family belongs to immune checkpoints, which their interactions with different receptors can elicit both stimulatory and inhibitory signals 23 . These family members are pivotal health and disease modulators of immune function 24 .…”
Section: Immune Checkpointsmentioning
confidence: 99%
“…This is the first signal for T cell activation, whereas a second signal is derived from costimulation where specific costimulatory molecules on APC interact with their receptors on T cells (Figure 1) [6]. The first signal alone does not lead to the immune response to allergen (Figure 1), it rather induces T cell unresponsiveness or "anergy" [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…They can act as costimulators or inhibitors/checkpoints. Currently, there are eleven known representatives of the B7 family, namely: B7-1 (CD80), B7-2 (CD86), B7-H1 (PD-L1, CD274), B7-DC (PDCD1LG2, PD-L2, CD273), B7-H2 (B7RP1, ICOS-L, CD275), B7-H3 (CD276), B7-H4 (B7x, B7S1, Vtcn1), B7-H5 (VISTA, Platelet receptor Gi24, SISP1), B7-H6 (NCR3LG1), B7-H7 (HHLA2), and ILDR2 (the synonyms of IChM names of the B7 family are given in parentheses) [7,8]. Two molecules of B7 family proteins [9], B7-1 and B7-2, are the best characterized costimulators [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…Receptors for the B7 family ligands expressed on the surface of T lymphocytes can deliver both stimulating and inhibitory signals that regulate the immune response [1,2]. Inhibitory receptor CTLA-4 (CD152) interact with ligands B7-1 (CD80) and B7-2 (CD86), while PD-1 (CD279) receptor binds B7-H1 (PD-L1, CD274) and B7-DC (PD-L2, CD273).…”
Section: Introductionmentioning
confidence: 99%
“…Inhibitory receptor CTLA-4 (CD152) interact with ligands B7-1 (CD80) and B7-2 (CD86), while PD-1 (CD279) receptor binds B7-H1 (PD-L1, CD274) and B7-DC (PD-L2, CD273). These molecules are also termed as immunological checkpoints [1,2]. Injections of monoclonal antibodies (mAb) blocking immunological checkpoints, such as CTLA-4, PD-1, and PD-L1, enhance antitumor immunity and lead to tumor rejection [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%